Sugimoto, E.; Matsuda, H.; Shibata, S.; Mizuno, Y.; Koyama, A.; Li, L.; Taira, H.; Ito, Y.; Awaji, K.; Yamashita, T.;
et al. Impact of Pretreatment Systemic Inflammatory Markers on Treatment Persistence with Biologics and Conventional Systemic Therapy: A Retrospective Study of Patients with Psoriasis Vulgaris and Psoriatic Arthritis. J. Clin. Med. 2023, 12, 3046.
https://doi.org/10.3390/jcm12083046
AMA Style
Sugimoto E, Matsuda H, Shibata S, Mizuno Y, Koyama A, Li L, Taira H, Ito Y, Awaji K, Yamashita T,
et al. Impact of Pretreatment Systemic Inflammatory Markers on Treatment Persistence with Biologics and Conventional Systemic Therapy: A Retrospective Study of Patients with Psoriasis Vulgaris and Psoriatic Arthritis. Journal of Clinical Medicine. 2023; 12(8):3046.
https://doi.org/10.3390/jcm12083046
Chicago/Turabian Style
Sugimoto, Eiki, Hiroki Matsuda, Sayaka Shibata, Yuka Mizuno, Asumi Koyama, Lixin Li, Haruka Taira, Yukiko Ito, Kentaro Awaji, Takashi Yamashita,
and et al. 2023. "Impact of Pretreatment Systemic Inflammatory Markers on Treatment Persistence with Biologics and Conventional Systemic Therapy: A Retrospective Study of Patients with Psoriasis Vulgaris and Psoriatic Arthritis" Journal of Clinical Medicine 12, no. 8: 3046.
https://doi.org/10.3390/jcm12083046
APA Style
Sugimoto, E., Matsuda, H., Shibata, S., Mizuno, Y., Koyama, A., Li, L., Taira, H., Ito, Y., Awaji, K., Yamashita, T., & Sato, S.
(2023). Impact of Pretreatment Systemic Inflammatory Markers on Treatment Persistence with Biologics and Conventional Systemic Therapy: A Retrospective Study of Patients with Psoriasis Vulgaris and Psoriatic Arthritis. Journal of Clinical Medicine, 12(8), 3046.
https://doi.org/10.3390/jcm12083046
